Clinical Trials Logo

Acute Biphenotypic Leukemia clinical trials

View clinical trials related to Acute Biphenotypic Leukemia.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT05170828 Withdrawn - Clinical trials for Acute Myeloid Leukemia

Cryopreserved MMUD BM With PTCy for Hematologic Malignancies

Start date: September 2022
Phase: Phase 1
Study type: Interventional

Multicenter single arm study to assess the safety and efficacy of allogeneic transplantation using cryopreserved bone marrow from deceased MMUD and PTCy, sirolimus and MMF for GVHD prophylaxis.

NCT ID: NCT03739606 Withdrawn - Acute Leukemia Clinical Trials

Flotetuzumab in Treating Patients With Recurrent or Refractory CD123 Positive Blood Cancer

Start date: October 20, 2020
Phase: Phase 2
Study type: Interventional

This phase II trial studies how well flotetuzumab works in treating patients with CD123 positive blood cancer that has come back or does not respond to treatment. Immunotherapy with monoclonal antibodies, such as flotetuzumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread.